Drug Shortage Report for MYLAN-LOSARTAN

Last updated on 2018-08-11 History
Report ID 51460
Drug Identification Number 02368293
Brand name MYLAN-LOSARTAN
Common or Proper name LOSARTAN
Company Name MYLAN PHARMACEUTICALS ULC
Market Status CANCELLED POST MARKET
Active Ingredient(s) LOSARTAN POTASSIUM
Strength(s) 100MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100 BT, 30 BL
ATC code C09CA
ATC description ANGIOTENSIN II ANTAGONISTS, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2018-07-03
Actual start date 2018-07-03
Estimated end date 2018-08-10
Actual end date 2018-08-10
Shortage status Resolved
Updated date 2018-08-11
Company comments Discontinued in report 53475
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2018-08-11 English Compare
v9 2018-08-10 French Compare
v8 2018-08-10 English Compare
v7 2018-07-31 French Compare
v6 2018-07-31 English Compare
v5 2018-07-05 French Compare
v4 2018-07-05 English Compare
v3 2018-07-04 English Compare
v2 2018-06-05 French Compare
v1 2018-06-05 English Compare

Showing 1 to 10 of 10